Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05171673

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury

Conditions: Soft Tissue Injuries

Sex: All
Ages: 6 Years – 45 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 151
Sponsor: IBSA Institut Biochimique SA

Location: Applied Research Center Little Rock Arkansas

Summary

A multi-center, prospective, open-label, controlled study of the pharmacokinetics and safety of the LicartTM topical system in pediatric and adult participants with minor soft tissue injuries. 150 male and female participants aged 6-16 and 18-45 with soft tissue injuries meeting the following criteria will be enrolled to evaluate the pharmacokinetics and safety of the Licart topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. The analgesic effects will also be evaluated of the topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. To collect principal investigator-reported global response to therapy.

Eligibility Criteria

Inclusion Criteria: 1. Willing to provide written informed consent; 2. Male or female, 6-11 years old; 12-16 years old; or 18-45 years old; 3. BMI \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05171673). StuddyBuddy aggregates publicly available trial information.